The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1537
Issue 1537
Antiviral Drugs for Seasonal Influenza 2017-2018; Betrixaban (Bevyxxa) for VTE Prophylaxis in Acute Medical Illness; Fiasp - Another Insulin Aspart Formulation for Diabetes; Triptorelin (Triptodur) for Central Precocious Puberty; In Brief: Pembrolizumab (Keytruda) for Cancers with Biomarkers (online only)
The full issue is available to subscribers Subscriber Login   
Antiviral Drugs for Seasonal Influenza 2017-2018

Antiviral drugs can be used for treatment and prophylaxis of influenza. Frequently updated information on influenza activity, testing for influenza, and antiviral resistance is available from the CDC at www.cdc.gov/flu.

RECOMMENDATIONS FOR TREATMENT — The CDC recommends starting antiviral treatment as soon as possible after illness onset, without waiting for the results of influenza testing.

Antiviral treatment is recommended for all persons with suspected or confirmed influenza who have severe, complicated, or progressive illness, require hospitalization, or are at higher risk for complications, including children <5 years old (especially those <2 years old), persons <19 years old receiving long-term aspirin therapy, adults ≥65 years old, morbidly obese persons (BMI ≥40), women who are pregnant or ≤2 weeks postpartum, persons of ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this issue:
Title: Issue 1537
Select version:
 Downloadable, electronic issue - $35
 Postal, hardcopy issue - $35